Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Ja
Clinical trial register · Brazil

Clinical Trials in Ja, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Brazil and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2237 matching records held by the registry are in this view. Synced 15 Nov 2026, 03:18 UTC
2237
Studies in scope
all four open statuses
1133
Recruiting now
open to new participants
355
Lead sponsors
across recruiting studies
Top sites
Porto Alegre 7 São Paulo 6 São José do Rio Preto 5 Curitiba 4 Barretos 4

Trials with a site in Ja

2 of 2237 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Brazil
Start
Active, closed
Exelixis
Phase 2/3
600
Passo Fundo, Porto Alegre, Jaú, Santo André, São José do Rio Preto, Barretos, Curitiba, Recife
2024-06-07
Active, closed
Exelixis
Phase 3
837
Salvador, Belo Horizonte, Curitiba, Porto Alegre, Barretos, Jaú, São Paulo
2018-06-10
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Brazilian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-brazil/city/ja

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Brazil and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,237 studies in total at the last sync on 15 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Ja that also match the filters currently applied.

How many clinical trials are recruiting in Ja?

0 of the 2 studies on this page are recruiting new participants as of the 15 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ja), 2 studies
PhaseStudiesRecruitingShare
Phase 2/31050%
Phase 31050%

Most active sponsors

Lead sponsors with the most studies (Ja)
Lead sponsorStudiesRecruiting
Exelixis20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.